By Michele Maatouk
Date: Friday 05 Apr 2024
(Sharecast News) - Johnson & Johnson said on Friday that it has agreed to buy Shockwave Medical, which develops products for the treatment of cardiovascular disease, for $13.1bn.
The US pharmaceutical and medical technologies company said the deal further extends Johnson MedTech's position in cardiovascular intervention and accelerates its shift into...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news